Fermented dairy foods (FDFs) and probiotics are promising tools for the prevention and
management of cardiometabolic diseases (CMDs), respectively. The relation between the …

Background & aims Evidence suggests that gut microbiota is a potential factor in the
pathophysiology of both obesity and related metabolic disorders. While individual …

Microorganisms that colonize the mammalian skin and cavity play critical roles in various
physiological functions of the host. Numerous studies have revealed strong associations …

Objective Adropin, a newly identified regulatory protein has garnered attention given its
potential role in metabolism regulation, especially glucose metabolism and insulin …

Studies have suggested that probiotics and synbiotics can improve body weight and
composition. However, randomized controlled trials (RCTs) demonstrated mixed results …

It is a well-established fact that the microbiome harboring the human body plays a critical
role in maintaining human health and can influence treatments against various ailments …

Obesity is a complex chronic metabolic disease that impairs health and reduces lifespan.
Therefore, effective strategies for the prevention and treatment of obesity are necessary …

Background & aims Overweight and obese individuals show changes in mechanisms
related to appetite due to several factors, including excess fat and gut microbiota imbalance …

Type 2 diabetes mellitus (T2DM) is one of metabolic diseases with the major inducer of
obesity. Due to the change in lifestyle and dietary structure, more and more people are …

Background: Clinical trials evaluating the effect of probiotics on cardiovascular intermediate
outcomes have been scarce in recent years. We systematically evaluated the efficacy of …